## Abstract The purpose of this study was to evaluate effects of human platelet‐rich plasma (PRP)‐containing fragmin/protamine microparticles (F/P MPs) as a protein carrier on neovascularization and granulation tissue formation. Frozen and thawed PRP contains high concentrations of various growth f
Megakaryocyte colony growth-supporting activities in human plasma: Modification by platelets and platelet membranes
✍ Scribed by Kazuo Yamasaki; Nazir Jamal; Kenneth G. Mann; Hans A. Messner
- Book ID
- 102885011
- Publisher
- John Wiley and Sons
- Year
- 1987
- Tongue
- English
- Weight
- 713 KB
- Volume
- 133
- Category
- Article
- ISSN
- 0021-9541
No coin nor oath required. For personal study only.
✦ Synopsis
Human megakaryocyte colonies are grown in methylcellulose with plateletpoor plasma and medium conditioned by phytohemagglutinin-stimulated leukocytes (PHA-LCM) as a source of megakaryocyte colony stimulating factor (MEG-CSF). The megakaryocyte colony growth-supporting activity in human plasma can be absorbed by intact platelets or degranulated platelet membranes. It was possible to recover the activity by solubilizing platelet mem- branes with cholic acid. Filtration of the solubilized platelet membrane preparations through a Sephadex GI00 column yielded at least two activity peaks. The molecular weight of these two activities differs from that of the growth-promoting activity in PHA-LCM.
A variety of culture conditions facilitate the growth of megakaryocyte colonies from human bone marrow and peripheral blood . The essential components for megakaryocyte colony formation in methylcellulose include human plasma and a source of megakaryocyte colony stimulating factor (MEG-CSF) . The latter may be provided by phytohemagglutinin-stimulated leukocyte conditioned medium (PHA-LCM), or more recently by recombinant human granulocyte-macrophage colony stimulating factor (GM-CSF) (
📜 SIMILAR VOLUMES
Contrary to a recent report [Rinder et al.: Blood 82:505, 19931, aspirin does inhibit the release of a-granule contents as well as inhibiting the release of dense granule contents by human platelets during ADP-induced aggregation in citrated platelet-rich plasma (PRP). Measurements were: percent rel